Cargando…
Podocalyxin as a Prognostic Marker in Gastric Cancer
BACKGROUND: Podocalyxin-like 1 (PODXL) is a cell-adhesion glycoprotein associated with aggressive tumor phenotype and poor prognosis in several forms of cancer. The aim of this study was to investigate PODXL expression in gastric cancer by use of two different antibodies. METHODS: By tumor-tissue mi...
Autores principales: | Laitinen, Alli, Böckelman, Camilla, Hagström, Jaana, Kokkola, Arto, Fermér, Christian, Nilsson, Olle, Haglund, Caj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682935/ https://www.ncbi.nlm.nih.gov/pubmed/26674770 http://dx.doi.org/10.1371/journal.pone.0145079 |
Ejemplares similares
-
Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014) -
Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome
por: Kasurinen, Aaro, et al.
Publicado: (2019) -
High PROX1 expression in gastric cancer predicts better survival
por: Laitinen, Alli, et al.
Publicado: (2017) -
Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015) -
Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis
por: Arpalahti, Leena, et al.
Publicado: (2018)